The Manufacturers Life Insurance Company Increases Stock Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• The Manufacturers Life Insurance Company increased its stake in Acadia Healthcare by 37.4%, owning approximately 669,878 shares valued at $20.3 million after purchasing 182,282 shares in the first quarter.
• Acadia Healthcare reported $0.83 earnings per share for the last quarter, exceeding estimates of $0.71, along with a revenue of $869.23 million, reflecting a year-over-year increase of 9.2%.
• Following recent price objective adjustments, Wall Street analysts maintain a consensus rating of "Moderate Buy" with a target price of $40.77, indicating mixed expectations for future performance.

The Manufacturers Life Insurance Company boosted its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 37.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 669,878 shares of the company's stock after purchasing an additional 182,282 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.73% of Acadia Healthcare worth $20,311,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. FORA Capital LLC lifted its stake in Acadia Healthcare by 72.0% during the 1st quarter. FORA Capital LLC now owns 20,980 shares of the company's stock valued at $636,000 after acquiring an additional 8,783 shares during the period. Hotchkis & Wiley Capital Management LLC acquired a new stake in Acadia Healthcare during the 1st quarter valued at approximately $6,974,000. AlphaQuest LLC lifted its stake in Acadia Healthcare by 1,456.0% during the 1st quarter. AlphaQuest LLC now owns 7,142 shares of the company's stock valued at $217,000 after acquiring an additional 6,683 shares during the period. Banco Bilbao Vizcaya Argentaria S.A. lifted its stake in Acadia Healthcare by 80.6% during the 1st quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 9,870 shares of the company's stock valued at $297,000 after acquiring an additional 4,404 shares during the period. Finally, Hsbc Holdings PLC lifted its stake in Acadia Healthcare by 41.6% during the 1st quarter. Hsbc Holdings PLC now owns 33,435 shares of the company's stock valued at $1,012,000 after acquiring an additional 9,824 shares during the period.

Wall Street Analyst Weigh In

ACHC has been the subject of several analyst reports. Mizuho decreased their target price on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research note on Wednesday, August 13th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Sunday, August 3rd. Barclays decreased their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. UBS Group decreased their target price on shares of Acadia Healthcare from $45.00 to $31.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Finally, Royal Bank Of Canada cut their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating for the company in a report on Wednesday, August 13th. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $40.77.

Acadia Healthcare Trading Up 0.3%

Shares of ACHC traded up $0.07 during mid-day trading on Friday, reaching $23.72. The stock had a trading volume of 2,022,387 shares, compared to its average volume of 2,332,455. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $79.82. The business's fifty day moving average is $22.21 and its 200 day moving average is $24.93. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 15.71, a P/E/G ratio of 4.65 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.12. The firm had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.